Active ingredientDithranolCat. No. P-D157-001CAS 1143-38-0Family · Pharmaceutical analytical standards
Dithranol
An anthracene derivative applied to the skin for psoriasis: it is the synthetic version of chrysarobin, the active principle of Goa powder, and its effect on psoriasis was discovered by Galewsky in 1916. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?Goa powder comes from the Brazilian tree Andira araroba: it is named after the Indian region of Goa, where it arrived around 1852.
Go to the active ingredient →Active ingredientDithranolCat. No. P-D157-001CAS 1143-38-0
Pharmacopoeial impurityDithranol EP Impurity ACat. No. P-D157-002CAS 90-44-8
Pharmacopoeial impurityDithranol EP Impurity BCat. No. P-D157-003CAS 117-10-2
Pharmacopoeial impurityDithranol EP Impurity CCat. No. P-D157-004CAS 31991-54-5
Pharmacopoeial impurityDithranol EP Impurity DCat. No. P-D157-005CAS 1715-81-7No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceDithranol CRSEDQM code D2953000Family DithranolImpurityDithranol impurity C CRSEDQM code D2953025Family DithranolImpurityDithranol impurity D CRSEDQM code D2953050Family DithranolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.